These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6172888)

  • 1. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI; Thenot JP; Stec GP; Atkinson AJ
    Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved liquid chromatographic determination of procainamide and N-acetylprocainamide in serum.
    Patel CP
    Ther Drug Monit; 1983 Jun; 5(2):235-8. PubMed ID: 6192559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method.
    MacKichan JJ; Coyle JD; Shields BJ; Boudoulas H; Lima JJ
    Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular actions and pharmacokinetics of desethyl-N-acetylprocainamide in the dog.
    Lertora JJ; King LW
    J Pharmacol Exp Ther; 1986 Sep; 238(3):893-9. PubMed ID: 2427689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of N-acetylprocainamide deacetylation.
    Stec GP; Ruo TI; Thenot JP; Atkinson AJ; Morita Y; Lertora JJ
    Clin Pharmacol Ther; 1980 Nov; 28(5):659-66. PubMed ID: 6160014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ; Ruo TI; Piergies AA
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma.
    Raphanaud D; Borensztejn M; Dupeyron JP; Guyon F
    Ther Drug Monit; 1986; 8(3):365-7. PubMed ID: 2428144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA; Coyle JD
    Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fluorescence polarization immunoassay with liquid chromatography for quantification of procainamide and N-acetylprocainamide in urine.
    Tisdale JE; Padhi ID; Ware JA; Svensson CK
    Ther Drug Monit; 1996 Dec; 18(6):693-7. PubMed ID: 8946667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
    Bruguerolle B; Jadot G
    J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.
    Lai CM; Kamath BL; Look ZM; Yacobi A
    J Pharm Sci; 1980 Aug; 69(8):982-4. PubMed ID: 6157019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of N-acetylprocainamide.
    Connolly SJ; Kates RE
    Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the TDX fluorescence polarization immunoassays for procainamide and n-acetylprocainamide.
    Sonsalla PK; Bridges RR; Jennison TA; Smith CM
    J Anal Toxicol; 1985; 9(4):152-5. PubMed ID: 2412001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.